|1.||Ceballos, Guillermo: 9 articles (12/2014 - 08/2008)|
|2.||Villarreal, Francisco: 7 articles (12/2014 - 08/2008)|
|3.||Hara, Yukihiko: 7 articles (10/2009 - 02/2002)|
|4.||Oteiza, Patricia I: 6 articles (07/2015 - 10/2006)|
|5.||Yang, Chung S: 6 articles (03/2015 - 04/2003)|
|6.||Ramirez-Sanchez, Israel: 6 articles (12/2014 - 09/2011)|
|7.||Chopra, Kanwaljit: 6 articles (05/2014 - 11/2003)|
|8.||Taub, Pam R: 6 articles (01/2014 - 06/2010)|
|9.||Hase, Tadashi: 6 articles (09/2013 - 06/2007)|
|10.||Tokimitsu, Ichiro: 6 articles (04/2013 - 06/2007)|
01/01/2014 - "The objectives of this study were to evaluate the potential of (-)-epicatechin to stimulate mitochondrial respiration in cancer cells and to selectively sensitize cancer cells to radiation. "
10/01/2005 - "Various studies have shown significant suppressive effects of catechin on mammalian cells, either tumor or normal cells, including lymphoid cells. "
01/01/2005 - "In additional studies, catechin, the main monomeric polyphenol of red wine, delayed tumor onset in this mouse model in a positive, linear relationship when incorporated into the diet at levels of 0.5-4 mmol/kg diet. "
07/01/2003 - "These studies were guided by assays of the putative catechin-vanilloid target protein tNOX, a cell surface growth-related enzymatic activity specific to cancer. "
10/01/2002 - "No significant effects on tumor onset were observed when mice consumed a diet supplemented with wine solids containing <0.22 mmol catechin/kg diet, whereas a previous study showed that wine solids with a similar total polyphenol concentration but containing approximately 4 times more catechin significantly delayed tumor onset by approximately 30 d compared with a control diet. "
04/01/2011 - "The nanocatechin group showed statistically significant decrease in bacterial growth and improvement in prostatic inflammation compared with the catechin group. "
08/01/2012 - "The objective of this study was to assess the catechin effect in GRX liver cells in activities such as cell growth and inflammation. "
07/01/2012 - "The current study was intended to evaluate the hepatoprotective effect of Epicatechin (EC) against radiation-induced oxidative stress, in terms of inflammation and lipid peroxidation. "
01/01/2012 - "This study was pathway of (-)-epicatechin (EC) in the prevention and treatment of intestine inflammation in acute and chronic rat models. "
01/01/2015 - "Moreover, (+)-catechin blocked the activation of Akt and its inhibition was shown to play a crucial role in LPS-induced inflammation in BV-2 microglial cells. "
11/01/1983 - "Induction of hepatitis did not affect the fast clearance of unchanged 3-O-methyl-(+)-catechin from plasma but plasma clearance of the metabolites was reduced from 112 to 89 ml/hr."
01/01/1987 - "For in vivo studies, HBV hepatitis patients were treated with cianidanol at a daily dose of 3.0 g cianidanol for seven days and were investigated before and after the treatment. "
10/01/1977 - "[A double-blind clinical study of the effect of a new molecule (+)-cyanidanol-3 on the course of the clinical symptoms and biological parameters of viral hepatitis]."
01/01/1987 - "Chronic HBV hepatitis patients showed a moderate decrease in NK cell activity compared to the controls, but after the cianidanol therapy their NK cell activity significantly rose to 68.0% +/- 9.5% (p less than 0.01). "
07/15/1985 - "["Catergen" in the treatment of hepatitis]."
|4.||Breast Neoplasms (Breast Cancer)
01/01/2001 - "Our data showed that mixed GTE and its individual catechin components were effective in inhibiting breast cancer and endothelial cell proliferation. "
04/01/2010 - "In conclusion, high epicatechin may be related to a reduced risk of breast cancer. "
04/01/2010 - "In spline regression, we found an overall dose-response relationship between epicatechin level and risk of breast cancer, although it was not apparent in low and middle urinary excretion range. "
04/01/2010 - "Urinary excretion of epicatechin was inversely associated with breast cancer risk [odds ratio (OR) and 95% confidence interval (CI) of 0.59 (0.39-0.88) for the intermediate tertile]. "
01/01/2008 - "Here we report an innovative enzymatic strategy for the oligomerization of catechins (specifically epicatechin) that yields stable, water-soluble oligomerized epicatechins with enhanced and highly specific anti-proliferative activity for human breast cancer cells. "
01/01/2011 - "The purpose of this research is to determine whether the specially manufactured GSE, catechin-rich GSE (CGSE), can protect against obesity induced by a high-fat diet (HFD) and to address the mechanism underlying this effect. "
06/01/2008 - "These findings suggest that ingestion of a catechin-rich beverage ameliorates serious obesity and cardiovascular disease risk factors without raising any safety concerns in Japanese children."
07/01/2009 - "These findings suggest that multiple effects of catechins, including anti-obesity and anti-cancer effects, are mediated, at least in part, by the activation of LKB1/AMPK in various tissues, and that these effects vary according to the catechin structure."
01/01/2012 - "This study compared the effect of RTP on biochemical and molecular markers of oxidative stress to equimolar doses (0.66 mmol) of RES and catechin-rich grape seed extract (CGSE) in a model of oxidative and metabolic stress associated with obesity in humans. "
03/01/2012 - "Green tea catechin has been proposed to have an anti-obesity effect. "
|2.||Catechin (Z 7300)
|3.||epigallocatechin gallate (epigallocatechin-3-gallate)
|6.||Glutathione (Reduced Glutathione)
|10.||Caffeine (No Doz)
|3.||Homologous Transplantation (Allograft)
|4.||Heterologous Transplantation (Xenotransplantation)
|5.||Home Nursing (Nursing, Home)